US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients
DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday said that the approval is for adult breast cancer patients who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
FDA approves new MCL treatment by AstraZeneca
WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation.
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...
FDA Bans Red Dye 3 On Cusp Of Potentially Big Changes In Food Industry
FDA’s ban on Red 3 is a shot across the bow to the food sector that could ironically help facilitate Kennedy’s pursuit of ...
A wave of cat deaths from bird flu prompts new rules on pet food production
Cats — both large cats in captivity and pet house cats — across multiple states have been dying from H5N1 bird flu. Now, ...
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
E-sellers of compounded weight-loss drugs fail to reveal risks, research shows
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
FDA bans Red No. 3 in food and ingested drugs. Here's when it has to be phased out by
Red No. 3, also known as erythrosine, is a color additive made from petroleum that gives foods and drinks a bright, ...
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...
How food brands and drugmakers are responding to FDA's ban of food dye Red 3
Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was revoking ...
abcnews42d
FDA bans Red 3 dye in food, drink and medicine due to cancer risk
Already banned in cosmetics and topical medicines since 1990, the Food and Drug Administration announced on Wednesday that ...
Biden administration moves to limit nicotine in cigarettes and certain other tobacco products
The US Food and Drug Administration is proposing limits on the level of nicotine in cigarettes and some other types of ...